US FDA sees boost in FY23 budget proposal but no diagnostics reform
Regulatory NewsFerdous Al-Faruque
APIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsComplianceDiagnostics/IVDsMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/Policy